Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Lncrna CASC11 aggravates diabetic nephropathy via targeting FoxO1
Yun Zhang1, Shuhan Shi1, Changda Lin1
1Second Affiliated Hospital of Fujian Medical University, Department of Renal Medicine, Quanzhou, China.
Background:
To explore the biological effects of CASC11 on aggravating diabetic nephropathy (DN) by regulating FoxO1 (forkhead transcription factor O1).
Methods:
Serum levels of CASC11 and FoxO1 in DN patients were detected. The possibility of CASC11 in predicting the onset of DN was analyzed by depicting ROC curves. Correlation between CASC11 and FoxO1 was evaluated by Pearson correlation test. After intervening CASC11 and FoxO1 levels, we found that changes in proliferative and migratory abilities in high glucose (HG)induced kidney mesangial cells were determined respectively. Protein levels of TGF-β1 and Smads regulated by both CASC11 and FoxO1 were examined by Western blot.
Insights
Circular RNA CASC11 exacerbates diabetic nephropathy (DN) by regulating the forkhead transcription factor O1 (FoxO1). This study investigates CASC11's role in DN pathogenesis and its association with FoxO1.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Diabetic nephropathy (DN) is a severe complication of diabetes.
- The role of circular RNA CASC11 in DN progression is not fully understood.
- Forkhead transcription factor O1 (FoxO1) is implicated in DN pathogenesis.
Purpose of the Study:
- To investigate the biological effects of CASC11 in aggravating DN.
- To explore the regulatory relationship between CASC11 and FoxO1 in DN.
- To assess CASC11 as a potential biomarker for DN onset.
Main Methods:
- Serum CASC11 and FoxO1 levels were measured in DN patients.
- Receiver operating characteristic (ROC) curves analyzed CASC11's predictive value for DN.
- Pearson correlation assessed the relationship between CASC11 and FoxO1.
- In vitro experiments examined cell proliferation and migration in high glucose-induced mesangial cells.
- Western blot analyzed protein levels of TGF-β1 and Smads.
Main Results:
- Serum CASC11 levels were significantly altered in DN patients.
- CASC11 showed potential in predicting DN onset.
- A significant correlation was observed between CASC11 and FoxO1 levels.
- CASC11 and FoxO1 intervention affected kidney mesangial cell proliferation and migration.
- CASC11 and FoxO1 regulated TGF-β1 and Smad protein expression.
Conclusions:
- CASC11 plays a crucial role in aggravating DN, partly through regulating FoxO1.
- CASC11 may serve as a potential diagnostic biomarker for DN.
- Targeting CASC11 and FoxO1 could offer therapeutic strategies for DN.
Related Concept Videos
lncRNA - Long Non-coding RNAs
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

